Brokerages Set Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Target Price at $416.33
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year price target among […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year price target among […]
